Case Report
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Dec 14, 2009; 15(46): 5859-5863
Published online Dec 14, 2009. doi: 10.3748/wjg.15.5859
Figure 1
Figure 1 Computed tomography (CT) showing well-vascularized mass within the duodenum and in the head of the pancreas. There is also a cystic lesion containing gas within the pancreatic mass.
Figure 2
Figure 2 Resected duodenum and pancreatic head specimen containing both tumors. A: Posterior aspect; B: Resected duodenum highlighting the duodenal tumor and common bile duct; C, D: Transected head of the pancreas showing the cystic pancreatic and duodenal tumors. DT: Duodenal tumor; PT: Pancreatic tumor; CBD: Common bile duct.
Figure 3
Figure 3 Histopathology. A: Mucosal and submucosal tumor infiltration of the duodenum, revealing an insular growth of rather uniform epithelioid cells (HE, × 25); B: The pancreatic tumor presenting as a hemorrhagic pseudocyst, with a thin peripheral layer of neoplastic proliferation (HE, × 56).
Figure 4
Figure 4 Duodenal tumor cells showing a non-homogeneous immunoreactivity against anti-chromogranin A antibody, but clear diffuse cytoplasmic immunohistochemical reactivity with anti-somatostatin antibody. A: Chromogranin A immunoreactivity, × 56; B: Somatostatin immunoexpression, labeled streptavidin biotin (LSAB) method, aminoethylcarbazole (AEC) visualization, × 56.
Figure 5
Figure 5 Pancreatic tumor cells showing strong immunoreactivity with anti-somatostatin antibody. A: Somatostatin immunoreactivity, × 100; B: Ki-67 protein immunoexpression, LSAB+ method, AEC visualization, × 100.